Cary Nobles Robertson

About

Cary Nobles Robertson is an Associate Professor of Urology at Duke University. He is affiliated with the Duke Department of Urology, located at Duke South, 40 Medicine Circle, Durham, NC. His professional roles include involvement in the Urology Residency Program and the Duke Urologic Oncology Fellowship, indicating a focus on urologic oncology and surgical training. His contact email is cary.robertson@duke.edu, and he is engaged in research and education within the department. The page does not provide additional details about his research focus, background, or key contributions.

Research topics

• Internal medicine
• Medicine
• Computer Science
• Radiology
• Artificial Intelligence
• Surgery
• Cardiology
• Psychiatry
• Family medicine
• Medical physics

Selected publications

• Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project

  Prostate Cancer and Prostatic Diseases · 2017-03-28 · 149 citations

  article
  PublisherDOI

• Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project

  World Journal of Urology · 2015-01-05 · 139 citations

  reviewOpen access
  PublisherOA PDFDOI

• Salvage high‐intensity focused ultrasound ( <scp>HIFU</scp> ) for locally recurrent prostate cancer after failed radiation therapy: Multi‐institutional analysis of 418 patients

  British Journal of Urology · 2017-01-07 · 77 citations

  article

  OBJECTIVE: To report the oncological outcome of salvage high-intensity focused ultrasound (S-HIFU) for locally recurrent prostate cancer after external beam radiotherapy (EBRT) from a multicentre database. PATIENTS AND METHODS: This retrospective study comprises patients from nine centres with local recurrent disease after EBRT treated with S-HIFU from 1995 to 2009. The biochemical failure-free survival (bFFS) rate was based on the 'Phoenix' definition (PSA nadir + 2 ng/mL). Secondary endpoints…

  PublisherDOI

• Available evidence on HIFU for focal treatment of prostate cancer: a systematic review

  International braz j urol · 2022 · 69 citations

  PURPOSE: Prostate cancer (PCa) is the second most common oncologic disease among men. Radical treatment with curative intent provides good oncological results for PCa survivors, although definitive therapy is associated with significant number of serious side-effects. In modern-era of medicine tissue-sparing techniques, such as focal HIFU, have been proposed for PCa patients in order to provide cancer control equivalent to the standard-of-care procedures while reducing morbidities and complicati…

  PublisherOA PDFDOI

• Illness uncertainty, partner support, and quality of life: A dyadic longitudinal investigation of couples facing prostate cancer

  Psycho-Oncology · 2019-08-16 · 32 citations

  article

  OBJECTIVE: Prostate cancer (PC) and its treatment often result in chronic, negative side-effects that affect both patients and their romantic partners. Illness uncertainty is a chronic stressor that impacts PC patients and their partners and, if left unmanaged, predicts decreased interpersonal functioning and quality of life (QOL) after treatment is complete. This study explored associations among psychosocial constructs, measured from both partners during the first year following a PC diagnosis…

  PublisherDOI

Frequent coauthors

• Thomas J. Polascik

  Duke Medical Center

  94 shared

• Judd W. Moul

  Duke University

  73 shared

• Wendy Demark‐Wahnefried

  University of Alabama at Birmingham

  50 shared

• David F. Paulson

  United States Department of Veterans Affairs

  49 shared

• Leon Sun

  Jiangnan University

  43 shared

• David Albala

  42 shared

• W. Marston Linehan

  National Cancer Institute

  32 shared

• Philip Walther

  Vienna Center for Quantum Science and Technology

  32 shared

Similar researchers at Duke University

• Glenn Michael Premingerh-109